Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    retinitis pigmentosa AND gene therapy
Show Display Options
Rank Status Study
1 Recruiting Gene Therapy for Blindness Caused by Choroideremia
Condition: Choroideremia
Intervention: Drug: rAAV2.REP1
2 Recruiting Repository for Inherited Eye Diseases
Conditions: Retinitis Pigmentosa;   Inherited Ophthalmic Diseases
Intervention:
3 Completed Gyrate Atrophy of the Choroid and Retina
Condition: Gyrate Atrophy
Intervention:
4 Completed Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: Vitamin A
5 Recruiting Molecular Genetics of Retinal Degenerations
Conditions: Retinal Degeneration;   Retinitis Pigmentosa
Intervention:
6 Recruiting Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients With Retinal Disease Due to MERTK Mutations
Condition: Retinal Disease
Intervention: Genetic: Recombinant Adeno-Associated Virus
7 Recruiting Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention: Genetic: UshStat
8 Recruiting Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Conditions: Inherited Ophthalmic Diseases;   Inherited Retinal Degeneration
Intervention: Drug: Interferon gamma-1b

Indicates status has not been verified in more than two years